STOCK TITAN

HawkEye 360, Inc. Stock Price, News & Analysis

HAWK NYSE

Welcome to our dedicated page for HawkEye 360 news (Ticker: HAWK), a resource for investors and traders seeking the latest updates and insights on HawkEye 360 stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect HawkEye 360's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of HawkEye 360's position in the market.

Rhea-AI Summary

HawkEye 360 (NYSE: HAWK) launched the roadshow for a proposed initial public offering on April 27, 2026. The offering consists of 16,000,000 shares with an expected price range of $24.00 to $26.00 per share and a 30-day overallotment option of 2,400,000 shares. The company intends to list on the New York Stock Exchange under the ticker HAWK. Lead book-runners include Goldman Sachs and Morgan Stanley, with several additional managers and co-managers named. A registration statement has been filed with the SEC but is not yet effective.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary

HawkEye 360 (NYSE:HAWK) filed a Form S-1 registration statement with the SEC on April 10, 2026 for a proposed initial public offering of common stock and intends to list on the New York Stock Exchange under the ticker HAWK.

The number of shares and the price range have not been determined. Goldman Sachs and Morgan Stanley are lead book‑running managers; several other banks are listed as bookrunners. The offering may not be sold until the registration statement is effective.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags